Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Investigational New Drug CDMO Market, by Region, 2019-2027 (USD Billion)
1.2.2. Investigational New Drug CDMO Market, by Product, 2019-2027 (USD Billion)
1.2.3. Investigational New Drug CDMO Market, by Service, 2019-2027 (USD Billion)
1.2.4. Investigational New Drug CDMO Market, by End-User, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Investigational New Drug CDMO Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Investigational New Drug CDMO Market Dynamics
3.1. Investigational New Drug CDMO Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Growing pharmaceutical industry
3.1.1.2. Increasing outsourcing services by pharmaceutical companies
3.1.2. Market Restraint
3.1.2.1. Compliance issues while outsourcing
3.1.3. Market Opportunities
3.1.3.1. Rising investment in R&D
Chapter 4. Global Investigational New Drug CDMO Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Investigational New Drug CDMO Market, by Product
a. Market Snapshot
5.1. Global Investigational New Drug CDMO Market by Product, Performance - Potential Analysis
5.2. Global Investigational New Drug CDMO Market Estimates & Forecasts by Product 2018-2027 (USD Billion)
5.3. Investigational New Drug CDMO Market, Sub Segment Analysis
5.3.1. Small Molecule
5.3.2. Large Molecule
Chapter 6. Global Investigational New Drug CDMO Market, by Service
b. Market Snapshot
6.1. Global Investigational New Drug CDMO Market by Service, Performance - Potential Analysis
6.2. Global Investigational New Drug CDMO Market Estimates & Forecasts by Service 2018-2027 (USD Billion)
6.3. Investigational New Drug CDMO Market, Sub Segment Analysis
6.3.1. Contract Development
6.3.2. Contract Manufacturing
Chapter 7. Global Investigational New Drug CDMO Market, by End-User
c. Market Snapshot
7.1. Global Investigational New Drug CDMO Market by End-User, Performance - Potential Analysis
7.2. Global Investigational New Drug CDMO Market Estimates & Forecasts by End-User 2018-2027 (USD Billion)
7.3. Investigational New Drug CDMO Market, Sub Segment Analysis
7.3.1. Pharmaceutical Companies
7.3.2. Biotech Companies
7.3.3. Others
Chapter 8. Global Investigational New Drug CDMO Market, Regional Analysis
8.1. Investigational New Drug CDMO Market, Regional Market Snapshot
8.2. North America Investigational New Drug CDMO Market
8.2.1. U.S. Investigational New Drug CDMO Market
8.2.1.1. Product breakdown estimates & forecasts, 2018-2027
8.2.1.2. Service breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-User breakdown estimates & forecasts, 2018-2027
8.2.2. Canada Investigational New Drug CDMO Market
8.3. Europe Investigational New Drug CDMO Market Snapshot
8.3.1. U.K. Investigational New Drug CDMO Market
8.3.2. Germany Investigational New Drug CDMO Market
8.3.3. France Investigational New Drug CDMO Market
8.3.4. Spain Investigational New Drug CDMO Market
8.3.5. Italy Investigational New Drug CDMO Market
8.3.6. Rest of Europe Investigational New Drug CDMO Market
8.4. Asia-Pacific Investigational New Drug CDMO Market Snapshot
8.4.1. China Investigational New Drug CDMO Market
8.4.2. India Investigational New Drug CDMO Market
8.4.3. Japan Investigational New Drug CDMO Market
8.4.4. Australia Investigational New Drug CDMO Market
8.4.5. South Korea Investigational New Drug CDMO Market
8.4.6. Rest of Asia Pacific Investigational New Drug CDMO Market
8.5. Latin America Investigational New Drug CDMO Market Snapshot
8.5.1. Brazil Investigational New Drug CDMO Market
8.5.2. Mexico Investigational New Drug CDMO Market
8.6. Rest of The World Investigational New Drug CDMO Market
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Covance Inc.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Charles River Laboratories Inc.
9.2.3. Cambrex Corporation
9.2.4. IQVIA Holdings Inc.
9.2.5. Syneos Health
9.2.6. Lonza
9.2.7. Catalent
9.2.8. Recipharm AB
9.2.9. Siegfried Holding AG
9.2.10. Thermo Fisher Scientific Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption